Vertex Pharmaceuticals Incorporated · NASDAQ:VRTX
McKechnie Duncan sold 1,541 Vertex Pharmaceuticals Incorporated shares (Form 4)
Traded Jul 2, 2026 · Filed Jul 7, 2026
On Jul 2, 2026, McKechnie Duncan (EVP, Chief Commercial Officer) sold 1,541 Vertex Pharmaceuticals Incorporated shares at US$519.00 for US$800K under a trading plan, leaving 11,001 shares. Filed Jul 7, 2026 (Form 4).
- Sold
- 1,541 shares
- Price
- US$519.00
- Value
- US$800K
- Holding after
- 11,001 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP, Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 2, 2026 | Common Stock | Sale | 1,541 | US$519.00 | 11,001 | Direct |